$SGMO / PFE have been pushing ahead at maximum speed with a rival gene therapy SB-525 that posted positive early responses
stronger data on durability could yet prevent $BMRN BioMarin from capturing and keeping market share
https://t.co/lg0DOfrrXW

PS: $PFE presents data tomorrow